Frontlight ResearchEarly access
Trial site
Tianjin Medical University Cancer Insititute & Hospital
- 4running trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Diffuse large B-cell lymphoma2 trials
- Mantle cell lymphoma1 trial
- Phase
- Phase 23 trials
- Phase 31 trial
- Status
- Recruiting2 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Tianjin Medical University Cancer Institute and Hospital4 trials
Running trials
Not yet recruiting
Recruiting
CRP Regimen in Treating Elderly Patients With Previously Untreated Double-Positive DLBCL
Recruiting
Glofitamab Combination With Chidamide in Patients With Recurrent/Refractory DLBCL
Enrolling by invitation
AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Diffuse large B-cell lymphoma2 recruiting
- Mantle cell lymphoma1 recruiting
Site data: ClinicalTrials.govUpdated 19 Nov 2026